POS0695 KZR-616, A SELECTIVE IMMUNOPROTEASOME INHIBITOR FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE COMPLETED DOSE ESCALATION PHASE 1B PORTION OF THE MISSION STUDY

R. Furie(Northwell Health), Samir V. Parikh(The Ohio State University Wexner Medical Center), J. Wang, D. Bomba, R. Leff(ScienceSouth), Christopher J. Kirk, Noreen Henig
Annals of the Rheumatic Diseases
May 25, 2021
Cited by 11

Abstract


Related Papers

No related papers found

Powered by citation graph analysis